GCA
PFE icon

Genesee Capital Advisors’s Pfizer PFE Stock Holding History

Genesee Capital Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,272
Closed -$219K – 123
2024
Q4 		$219K Sell
8,272
-340
-4% -$9.22K 0.1% 114
2024
Q3 		$249K Buy
+8,612
New +$251K 0.12% 105

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Genesee Capital Advisors's PFE Position: Q1 2025 in Review

Genesee Capital Advisors sold out of Pfizer (PFE) in Q1 2025, closing a stake of 8,272 shares — an estimated $219K sold.

Genesee Capital Advisors first reported a position in PFE in Q3 2024 and held it in 2 quarters. The position peaked at $249K in Q3 2024. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Genesee Capital Advisors reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • Genesee Capital Advisors sold 8,272 Pfizer shares in Q1 2025, an estimated $219K.
  • Genesee Capital Advisors first reported a position in Pfizer in Q3 2024 and held it in 2 quarters.
  • Genesee Capital Advisors's Pfizer position peaked at $249K in Q3 2024.
  • 2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Genesee Capital Advisors's 13F filing for Q1 2025, filed 22 Apr 2025.